Anal HPV infection and associated precancerous lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Participants =18 years old. (2) Participants must identify as men who have sex with men, have had active or passive anal sex with other men in the past 365 days. (3) Participants who provide written informed consent.
Exclusion criteria
Exclusion criteria: (1) Treatment for anal intraepithelial neoplasia (AIN) or other anal lesions in the past 6 months. (2) Having other serious illnesses. (including malignant tumors, severe cardiovascular and cerebrovascular diseases, advanced chronic diseases, deep coma, permanent paralysis, severe brain damage, severe Parkinson's disease and severe mental illness, etc.) (3) Participating in HPV vaccine clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of any type of HPV in the anus of MSM population;The infection rate of high-risk HPV, 9v-HPV and low-risk HPV in anus of MSM population;Abnormal rate of cytological diagnosis;Abnormal rate of histopathological diagnosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| HIV+ / HIV-MSM population random HPV infection rate;HIV+ / HIV-MSM population high risk HPV, 9v-HPV, low risk HPV infection rate;Abnormal cytological diagnosis rate and histopathological diagnosis rate of HIV+ / HIV-MSM population; | — |
Countries
China
Contacts
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College